Poseida Therapeutics, Inc.

Q3 2022 13F Holders

Symbol
PSTX
CUSIP
73730P108
Type
Equity
Class
COM
Num filers
69
Total reported value, excl. options
$142M
Manager Report Date Value ($000) Shares